Shimadzu Corp. Hits Day Low of JPY 4,109 Amid Price Pressure

Shimadzu Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.31% as of October 29, 2025. The stock reached an intraday low of JPY 4,109.00, reflecting a challenging trading session.
In terms of performance metrics, Shimadzu's one-day performance contrasts with the Japan Nikkei 225, which fell by only 0.58%. Over the past week, Shimadzu has shown a modest increase of 1.5%, although this is slightly below the Nikkei's 1.83% gain. The company's one-month performance stands at 10.42%, while it has faced a decline of 8.68% over the past year, significantly underperforming the Nikkei's impressive 30.08% return.

Despite its current challenges, Shimadzu maintains a strong management efficiency with a return on equity (ROE) of 10.69% and a low debt profile. However, the stock's valuation remains elevated, trading at a price-to-book ratio of 2.18, which is above the average historical valuations of its peers. As the company navigates these market dynamics, its performance continues to be closely monitored.